These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22354133)

  • 1. The effect of exenatide and erythromycin on postprandial symptoms and their relation to gastric functions.
    Yoon SB; Choi MG; Lim CH; Kim JS; Cho YK; Park JM; Lee IS; Kim SW; Choi KY; Chung IS
    Digestion; 2012; 85(3):211-8. PubMed ID: 22354133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients.
    Gonlachanvit S; Hsu CW; Boden GH; Knight LC; Maurer AH; Fisher RS; Parkman HP
    Dig Dis Sci; 2003 Mar; 48(3):488-97. PubMed ID: 12757160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers.
    Talley NJ; Camilleri M; Burton D; Thomforde G; Koch K; Rucker MJ; Peterson J; Zinsmeister AR; Earnest DL
    Aliment Pharmacol Ther; 2006 Sep; 24(5):859-67. PubMed ID: 16918891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low doses of erythromycin on the 13C Spirulina platensis gastric emptying breath test and electrogastrogram: a controlled study in healthy volunteers.
    DiBaise JK; Park FL; Lyden E; Brand RE; Brand RM
    Am J Gastroenterol; 2001 Jul; 96(7):2041-50. PubMed ID: 11467630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study.
    Grudell AB; Camilleri M; Burton DD; Stephens DA
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1037-43. PubMed ID: 16984497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study.
    Delgado-Aros S; Camilleri M; Castillo EJ; Cremonini F; Stephens D; Ferber I; Baxter K; Burton D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10):997-1006. PubMed ID: 16234046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers.
    Castillo EJ; Delgado-Aros S; Camilleri M; Burton D; Stephens D; O'Connor-Semmes R; Walker A; Shachoy-Clark A; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G363-9. PubMed ID: 15246968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial.
    Bouras EP; Talley NJ; Camilleri M; Burton DD; Heckman MG; Crook JE; Richelson E
    Am J Gastroenterol; 2008 Aug; 103(8):2043-50. PubMed ID: 18803000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
    Linnebjerg H; Kothare PA; Skrivanek Z; de la Peña A; Atkins M; Ernest CS; Trautmann ME
    Diabet Med; 2006 Mar; 23(3):240-5. PubMed ID: 16492205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.
    Jacob D; Busciglio I; Burton D; Halawi H; Oduyebo I; Rhoten D; Ryks M; Harmsen WS; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G505-G510. PubMed ID: 28814387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans.
    Foxx-Orenstein A; Camilleri M; Stephens D; Burton D
    Gut; 2003 Nov; 52(11):1555-61. PubMed ID: 14570722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.
    Linnebjerg H; Park S; Kothare PA; Trautmann ME; Mace K; Fineman M; Wilding I; Nauck M; Horowitz M
    Regul Pept; 2008 Nov; 151(1-3):123-9. PubMed ID: 18675854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects.
    Keller J; Trautmann ME; Haber H; Tham LS; Hunt T; Mace K; Linnebjerg H
    Regul Pept; 2012 Nov; 179(1-3):77-83. PubMed ID: 22960288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
    Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
    Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a test to measure gastric accommodation in humans.
    Kuiken SD; Samsom M; Camilleri M; Mullan BP; Burton DD; Kost LJ; Hardyman TJ; Brinkmann BH; O'Connor MK
    Am J Physiol; 1999 Dec; 277(6):G1217-21. PubMed ID: 10600819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric accommodation influences proximal gastric and total gastric emptying in concurrent measurements conducted in healthy volunteers.
    Wang XJ; Burton DD; Breen-Lyles M; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G759-G767. PubMed ID: 33719546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia.
    Kim DY; Delgado-Aros S; Camilleri M; Samsom M; Murray JA; O'Connor MK; Brinkmann BH; Stephens DA; Lighvani SS; Burton DD
    Am J Gastroenterol; 2001 Nov; 96(11):3099-105. PubMed ID: 11721755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.
    Choung RS; Talley NJ; Peterson J; Camilleri M; Burton D; Harmsen WS; Zinsmeister AR
    Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study.
    Malloy J; Capparelli E; Gottschalk M; Guan X; Kothare P; Fineman M
    Clin Ther; 2009 Apr; 31(4):806-15. PubMed ID: 19446153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonographic assessment of the effect of metoclopramide, erythromycin, and exenatide on solid-phase gastric emptying in healthy cats.
    Husnik R; Gaschen FP; Fletcher JM; Gaschen L
    J Vet Intern Med; 2020 Jul; 34(4):1440-1446. PubMed ID: 32515089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.